More from OVALTINE
Ovaltine Cocoa Drink Powder 400g
Pack size : 400g
KES 1400.00(Inc. VAT)
Only 7 left!
Sold & Delivered by Carrefour
Origin -
Kenya
highlights
Ovaltine provides 12 essential vitamins and minerals with no artificial flavours or sweeteners and has less than half the sugar of the leading chocolate syrup brand. Ovaltine also makes a great addition to smoothies, baked goods or sprinkled over ice cream.
Get it delivered by:
Today 10 AM - 12 PM
1
DESCRIPTION
Ovaltine is perfect for you. It is known for its delicious ‘chocolatey’ malt taste. Ovaltine provides 12 essential vitamins and minerals with no artificial flavours or sweeteners and has less than half the sugar of the leading chocolate syrup brand. Ovaltine also makes a great addition to smoothies, baked goods or sprinkled over ice cream.
Nutrition facts
Per100PortionType
Average Nutritional Value As Per 100g
Per100Energyinkcal
398kcal
Per100EnergyinkJ
1742kJ
Per100Protein
7.1g
Per100Carbohydrates
73.4g
Per100Sugar
42.0g
Per100Fat
6.8g
Per100Fibre
2.8g
Per100Sodium
0.27g
Sub Type
Drink Powder
Form
Powder
Category
Food
Flavour
Cocoa
*Your daily values may be higher or lower depending on your calaries needs
INFORMATION
Ingredients
Barley Malt Extract● Sugar● Glucose Syrup● Milk Powder● Hydrogenated Palm Kernal Oil● Cocoa Powder● Calcium● Magnesium● Phosphorus● Iron● Zinc● Sodium Caseinate● Salt● Emulsifier (E471● E472E)● Dipotassium Hydrozen Phosphate● Sodium Tripolyphosphate● Vanillin.
Allergy Information
Contains Gluten.
Storage Condition
Store in a cool and dry place.
Preparation and usage
Ready to use.
Brand Message
Ovaltine (also known by its original name Ovomaltine) is a brand of milk flavoring product made with malt extract (except in the blue packaging in the United States), sugar (except in Switzerland), and whey. Some flavors also have cocoa. Ovaltine, a registered trademark of Associated British Foods, is made by Wander AG, a subsidiary of Twinings, which acquired the brand from Novartis in 2002,[1] except in the United States, where Nestle acquired the rights separately from Novartis in the late 2000s.